Clinical Trial Update: A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating co-administration of Bremelanotide with Tirzepatide for obesity; the study is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Vyleesi (Bremelanotide)
• ZEPBOUND (tirzepatide)

Snippet

Sponsor: Palatin Technologies, Inc | Conditions: Obesity | Phase 2 | Status: ACTIVE_NOT_RECRUITING